Crinetics Pharmaceuticals Inc (CRNX) — Financial Flexibility Index
Crinetics Pharmaceuticals Inc (CRNX) has a Financial Flexibility Index of -1.03x as of March 2026. Free cash flow of $-123.88 Million (operating CF $-124.70 Million minus capex $820.00K) represents -1% of total liabilities ($120.68 Million). Also explore CRNX net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Crinetics Pharmaceuticals Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Crinetics Pharmaceuticals Inc across 10 annual periods. Check CRNX strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Crinetics Pharmaceuticals Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Crinetics Pharmaceuticals Inc. For the full company profile including market capitalisation, see CRNX market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.60x | $-372.16 Million | $-377.92 Million | $143.41 Million | ▼ -28.3% |
| 2024 | -2.02x | $-222.13 Million | $-225.97 Million | $109.79 Million | ▼ -20.5% |
| 2023 | -1.68x | $-161.62 Million | $-166.31 Million | $96.25 Million | ▲ +47.0% |
| 2022 | -3.17x | $-113.55 Million | $-115.20 Million | $35.85 Million | ▲ +31.5% |
| 2021 | -4.62x | $-88.15 Million | $-88.59 Million | $19.07 Million | ▼ -8.6% |
| 2020 | -4.26x | $-61.84 Million | $-62.03 Million | $14.53 Million | ▼ -22.8% |
| 2019 | -3.47x | $-45.89 Million | $-46.38 Million | $13.24 Million | ▼ -110.8% |
| 2018 | -1.64x | $-18.40 Million | $-19.46 Million | $11.19 Million | ▼ -448.8% |
| 2017 | -0.30x | $-9.18 Million | $-9.48 Million | $30.62 Million | ▼ -6.7% |
| 2016 | -0.28x | $-5.28 Million | $-5.47 Million | $18.80 Million | — |